Short-term growth in asthmatic children using fluticasone propionate

Chest. 1998 Mar;113(3):584-6. doi: 10.1378/chest.113.3.584.

Abstract

Background: Inhaled corticosteroids may reduce short-term growth velocity in asthmatic children and knemometry is the most sensitive tool to detect this short-term growth suppression.

Study objective: To compare lower leg growth velocity, as measured by knemometry, in asthmatic children during and after treatment with inhaled fluticasone propionate (FP), 100 microg twice daily.

Design: Nonrandomized open trial.

Setting: University hospital, outpatient clinic for pediatric pulmonology.

Patients: Twenty-one asthmatic children (13 boys), aged 6 to 10 years.

Interventions: Inhalation of FP from a dry powder inhaler, 100 microg, twice daily for 6 weeks, followed by 2 weeks during which only an inhaled beta2-agonist was used on demand (washout). During treatment and washout periods, patients were seen every 2 weeks at the same time of day.

Measurements and results: Lower leg growth velocity measured by knemometry during FP treatment was not significantly different from that during washout (p=0.33, one-way analysis of variance).

Conclusions: No significant suppression of lower leg growth velocity was found in prepubertal asthmatic children using FP, 100 microg, by dry powder inhaler twice daily for 6 weeks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Administration, Topical
  • Androstadienes / administration & dosage
  • Androstadienes / therapeutic use*
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use*
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Child
  • Female
  • Fluticasone
  • Glucocorticoids
  • Growth / drug effects*
  • Humans
  • Leg / growth & development
  • Male

Substances

  • Androstadienes
  • Anti-Asthmatic Agents
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Fluticasone